Polycyclic aromatic hydrocarbon induced molecules
CA 2382622 A1 · Owner: Incyte Pharmaceuticals, Inc. · Inventors: Kaser, Matthew R.; Azimzai, Yalda; Yue, Henry
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides novel nucleic acid molecules and encoded proteins associated with response to polycyclic aromatic hydrocarbon exposure. The invention also provides expression vectors host cells, and antibodies. The , invention also provides methods for screening or purifying ligands and diagnosing, treating or preventing disorders associated with polycyclic aromatic hydrocarbon exposure.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 22, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 22, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 22, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.